As many countries across meso-America come closer to elimination goals, understanding the transmission potential in areas where little to no transmission has occurred in the recent years becomes increasingly important to guide elimination and prevent local re-introduction of transmission
Enormous progress has been made in recent years in developing techniques for malaria genetic surveillance.
As Southern Angola aims to scale up their application of IRS, a targeted approach will allow
for maximal impact.
MAP and researchers in India are embarking on a project to create improved maps and burden estimates for malaria
In collaboration with Sudanese researchers and the Sudanese Ministry of Health, MAP created high-resolution maps and burden estimates of malaria burden in Sudan
MAP’s work on global drug and diagnostic use is supplemented by this project, done in partnership with the PMI:Insights consortium to answer case-management and commodity quantification questions raised by PMI teams based in Guinea, Mozambique, Uganda and Zambia.
MAP, in partnership with CHAI IVCC,Swiss TPH, MMV and RBM, has produced global forecasts of demand for important malaria commodities forward to 2031. MAP provided estimates of historical and projected need, demand and consumption of ITNs, RDTs and antimalarials including ACTs.
MAP produces high-resolution estimates of Plasmodium falciparum prevalence, incidence, and mortality.
MAP produces high-resolution maps and burden estimates for Plasmodium vivax.
Seasonal Malaria Chemoprevention (SMC) is the monthly administration of antimalarials sulfadoxine-pyrimethamine and amodiaquine (SP + AQ) to children at risk during a country’s peak malaria season.